1.Clinical Curative Effect of Amoxicillin/Clavulanate Potassium in the Treatment of Children with Suppura-tive Tonsillitis
China Pharmacist 2014;(4):633-634
Objective:To analyze the clinical efficacy and safety of amoxicillin and clavulanate potassium in the treatment of chil-dren with suppurative tonsillitis. Methods:Totally 263 children with suppurative tonsillitis from March 2011 to September 2013 in pe-diatrics were randomly divided into two groups, the control group had 130 cases and the treatment group had 133 cases. All the patients were given conventional treatment, meanwhile, the control group was with intravenous infusion of azithromycin, and the treatment group was orally given amoxicillin and clavulanate potassium dispersible tablets. The clinical efficacy, clinical symptom disappearance time and the incidence of adverse reactions of the two groups were observed. Results:After the treatment, the control group were cured with the total effective rate of 83. 8%, and the treatment group were healed with the total effective rate of 90. 2%. The difference wasn't sig-nificant (P>0. 05). Orally used amoxicillin and clavulanate potassium was more economic and convenient, which could reduce the drug-resistance as well. There was no significant difference in the effects on fever, purulent and the white blood cell between the two groups, and no significant adverse reactions showed in both groups. Conclusion:Orally used amoxicillin and clavulanate potassium ex-hibits obvious therapeutic effect on infantile suppurative tonsillitis, which can effectively improve the clinical symptoms without obvious adverse reactions, and it is worthy of clinical use.
5.Experiment Study of Anti-inflammatory and Analgesia Activity of Danweisan
Chenlie YU ; Qiyang SHOU ; Weimin ZHOU
Journal of Zhejiang Chinese Medical University 2006;0(04):-
[Objective]To observe the activity of anti-inflammatory and analgesia of Danweisan.[Methods]The analgesia action of Danweisan was determined with twisting method,and the anti-inflammatory effect of Danweisan was evaluated with xylene induced ear tumefaction.The effects of the small,medium,large dosages of Danweisan group(2,3,4g/kg) on twisting and ear tumefaction in mouse were assessed.[Results] Compared with the normal group,it was shown to exert dramatic inhibitory effect with concentration-dependence on mouse twisting and ear tumefaction in the Danweisan group.[Conclusion]Danwesan has a remarkable analgesia activity and a better anti-inflammatory action than asprine.
9.Reverse radial side of dorsal artery the fascial pedicle island bone flap in repairing defect of thumb composite tissue defects
Xiao ZHOU ; Yongjun RUI ; Mingyu XUE ; Yajun XU ; Kuishui SHOU
Chinese Journal of Orthopaedics 2013;33(11):1104-1108
Objective To introduce the surgical method of reverse radial side of dorsal artery the fascial pedicle island bone flap for the treatment of thumb composite tissue defects,and to evaluate its short term clinical outcome.Methods From May 2010 to March 2012,9 cases with composite tissue defects at thumb were treated with reverse radial side of dorsal artery the fascial pedicle island bone flap,including 5 males and 4 female with an average age of 38 years (range,13-68).All injuries were caused by planer.The time of injury to operation was 3-8 hours,all patients showed in both thumb root plane beyond volar or dorsal,skin and soft tissue defect accompanied by distal phalanx defect.Skin and soft tissue of thumb defect size was 1.0 cm ×1.8 cm to 2.0 cm × 2.2 cm.Preoperative hands anteroposterior and lateral X-ray were routine taken.Imaging findings were associated with the thumb base beyond the distal phalanx fractures,bone defect length was 0.4-0.7 cm.We cut thumb radial side of the dorsal artery fascia flap during surgery operation according to the thumb side wound defect case.The size of the bone flap was 0.2 cm× 0.6 cm to 0.4 cm × 0.8 cm,properly inserting intramedullary distal phalanx fixed base,9-0 line will flap inside the dorsal nerve and a nerve suture flap reconstruction feeling.Results All bone flaps were survived completely,no case occur venous disorders,flap blood circulation was stable,donor skin graft was survival in stage Ⅰ.This group of patients incision were healing 2 weeks after surgery.All the patients were followed up as scheduled,and the follow-up time was 6-12 months.All flaps survived,and the colors,texture,contour of the flaps were good.The two-points discrimination distance was 7.0-10.0 mm on the flap,Thumb distal phalanx healing time was 1.0-1.5 months.Bone absorption was not observed in graft.The thumb function was assessed as excellent in 7 fingers,good in 2 fingers,no complication occurred in donor site.Conclusion The main artery and nerve will not be sacrifice,when the bone flap is used.There are blood into the backbone of the first metacarpal nearly 1/3 of the bone to reconstruct thumb bone defect,the operative procedures is available and easy to be performed,which is a new method for the treatment of thumb composite tissue defects.
10.Clinical study of lobaplatin combined with vinorelbine for non-small cell lung cancer
Xiaojie WANG ; Tao SHOU ; Qing CHEN ; Bo ZHOU
China Oncology 2009;19(12):929-932
Background and purpose. Chemotherapy is a standard treatment for patients with advanced stage non-small cell lung cancer (NSCLC) However, platinum based chemotherapeutic regimen haves high toxicity profile to normal tissues. Lobaplatin (LBP) is a new third-generation antitumour platinum drug. Studies abroad have shown that Iobaplatin has an anticancer activity similar to cisplatin with better tolerance and is more effective for those who are resistant to cisplatin. This study was aimed to observe the effectiveness and toxicities of lobaplatin combined with vinorelbine (NVB) for the treatment of advanced NSCLC. Methods: Sixty-four patients pathologically diagnosed as clinical stage Ⅲ_B-Ⅳ NSCLC who did not receive treatment before, were randomly assigned to two groups. NL group (NVB+LBP): LBP at a dose of 30 mg/m~2 intravenous infusion on day 1, and NVB at a dose of 25 mg/m~2 intravenous infusion on days 1 and 8. NP group (NVB+DDP): Cisplatin (DDP) at a dose of 30 mg/m~2 intravenous infusion on day 1, 2 and 3 and NVB at a dose of 25 mg/m~2 intravenous infusion on days 1 and 8. Treatments were repeated every 21-28 days for 3 cycles. Results: For 34 patients of NL group, there were CR (1 cases), PR(13 cases), NC(15 cases), and PD(5 cases). The overall response rate (RR) was 41.2%, disease control rate (DCR) was 85.3%. In NP group: RR was 43.3%, DCR was 83.3% (X~2=0.05, P>0.05). Median overall survival time was 8.6 months and 8.9 months for NL group and NP group, respectively. The main toxicities in NL group were myelosuppression. Digestive toxicity such as anorexia, nausea,vomiting were less than those in the NP group (X~2=7.43, P<0.05), Peripheral hour,toxicity, serious liver and renal toxicity were not observed in NL group. Conclusion: Compared with cisplatin plus vinorelbine, domestic lobaplatin with vinorelbine yielded similar efficacies for NSCLC, but had less toxicity and well tolerate.